In a lengthy statement revealing plans to strengthen the agency’s regulation of dietary supplements, FDA Commissioner Scott Gottlieb, M.D., expressed concern that “changes in the supplement market may have outpaced...
FDA's top official disclosed Thursday his agency is considering whether it should pursue the issuance of a regulation that would authorize the use of CBD in foods and dietary supplements.
FDA’s top official on Wednesday announced a new working group within his agency to improve oversight of the dietary supplement industry.
The opioid crisis has spurred several supplement brands to make claims about easing withdrawal symptoms and making quitting easier, but such brands are currently facing legal action.
The bill passes both the Senate and U.S. House of Representatives, and is expected to be signed into law by the president in the coming week.
Through an analysis of an FDA database, researchers from California have identified nearly 800 products marketed as supplements but adulterated with unapproved pharmaceutical ingredients. The study prompted critics of...
The July 31 warning letter reflects FDA's continuing concern over the marketing of CBD products—including supplements—to treat diseases like cancer and schizophrenia without agency drug approval.
FDA has approved a cannabidiol-based drug derived from marijuana. Its top official said the agency remains concerned over claims that unapproved CBD products can cure or treat diseases like cancer.
An appeals court dismisses a petition challenging the DEA’s marijuana extract rule.
Supporters call new hemp legislation a “dream wish list” for all things cannabis.